Acute inflammatory demyelinating polyneuropathy as the initial presentation of lupus

American Journal of Emergency Medicine

Volumn 27, Issue 7, 2009, Pages 900.e3-900.e5

  Hsu, Tai Yi ^a   Wang, Shih Hao ^a   Kuo, Chang Fu ^a   Chiu, Te Fa ^a   Chang, Yu Che ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE INFLAMMATORY DEMYELINATING POLYNEUROPATHY; ADULT; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; ELECTROPHYSIOLOGY; EMERGENCY WARD; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; LABORATORY TEST; MUSCLE STRENGTH; MUSCLE WEAKNESS; PARESTHESIA; PHYSICAL EXAMINATION; PLASMAPHERESIS; POLYNEUROPATHY; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 68349101410     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2008.11.006     Document Type: Article

References (17)

1. Griffin J.W., and Sheikh K. The Guillain-Barré syndrome. In: Dyck P.J., and Thomas P.K. (Eds). Peripheral neuropathy. 4th ed (2005), Elsevier Saunders, Philadelphia (Pa) 2197-2219
2. Tan E.M., Cohen A.S., Fries J.F., et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25 (1982) 1271-1277
3. Hochber M.C. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40 (1997) 1725
4. Endo T., Scott D.D., Stewart S.S., et al. Antibodies to glycosphingolipids in patients with multiple sclerosis and SLE. J Immunol 132 (1984) 1793-1797
5. Ilyas A.A., Willison H.J., Quarles R.H., et al. Serum antibodies to gangliosides in Guillain-Barré syndrome. Ann Neurol 23 (1988) 440-447
6. Jacobs B.C., van Doorn P.A., Schmitz P.I., et al. Campylobacter jejuni infection and anti-GM1 antibodies in Guillain-Barré syndrome. Ann Neurol 40 (1996) 181-187
7. Zeballos R.S., Fox R.I., Cheresh D.A., et al. Anti-glycosphingolipid autoantibodies in rheumatologic disorders. J Clin Lab Anal 8 (1994) 378-384
8. Johnson R.T., and Richardson E.P. The neurological manifestations of systemic lupus erythematosus: a clinical-pathological study of 24 cases and review of the literature. Medicine 47 (1968) 337-369
9. Feinglass E.J., Arnett F.C., Dorseh C.A., et al. Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease. Medicine 55 (1976) 323-339
10. Mok C.C., Lau C.S., and Wong R.W.S. Neuropsychiatric manifestations and their clinical associations in southern Chinese patients with systemic lupus erythematosus. J Rheumatol 28 (2001) 766-771
11. Millette T.J., Subramony S.H., Wee A.S., et al. Systemic lupus erythematosus presenting with recurrent acute demyelinating polyneuropathy. Eur Neurol 25 (1986) 397-402
12. Chaudhuri K.R., Taylor I.K., Niven R.M., et al. A case of systemic lupus erythematosus presenting as Guillain-Barré syndrome. Br J Rheumatol 28 (1989) 440-442
13. Matsuki Y., Hidaka T., Matsumoto M., et al. Systemic lupus erythematosus demonstrating serum anti-GM1 antibody, with sudden onset of drop foot as the initial presentation. Internal Med 38 (1999) 729-732
14. Hughes R.A., Wijdicks E.F., Barohn R., et al. Practice parameter: immunotherapy for Guillain-Barré syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 61 (2003) 736
15. Plasmapheresis and acute Guillain-Barré syndrome. The Guillain-Barré syndrome Study Group. Neurology 35 (1985) 1096-1104
16. Aranow C., and Ginzler E.M. Treatment of non-renal lupus. In: Hochberg M.C., Silman A.J., Smolen J.S., Weinblatt M.E., and Weisman M.H. (Eds). Rheumatology. 4th ed (2008), Mosby/Elsevier, Philadelphia 1309-1318
17. Schlansky R., DeHoratius R.J., Pincus T., et al. Plasmapheresis in systemic lupus erythematosus: cautionary note. Arthritis Rheum 24 (1981) 49-58